FORMATION OF ANDROSTANEDIOL FROM C-13-LABELED TESTOSTERONE IN HUMANS

被引：6

作者：

VIERHAPPER, H

机构：

[1] Division of Clinical Endocrinology and Diabetes Mellitus, I. Medizinische Universitätsklinik, Wien

来源：

STEROIDS | 1990年 / 55卷 / 04期

关键词：

androstanediol; human infusion; mass-spectrometry; steroids; testosterone;

D O I：

10.1016/0039-128X(90)90107-M

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The determination of urinary 5α-androstane-3α,17β-diol (3a-Diol) by gas chromatography/mass spectrometry during and after the infusion of stable-labeled testosterone (T) represents an alternative to the use of radioactive label for turnover studies in vivo. Using this methodology to assess the urinary excretion rates of T and 3a-Diol in healthy men (n = 6) and women (n = 5) during and after the intravenous infusion (t = 4 hours) of 20 mg (men) or 5 mg (women) [13C]testosterone, the cumulative renal excretion of 13C-labeled T was found to be 15.6 ± 9.6 μg/24 hours (men) and 1.1 ± 1.6 μg/24 hours (women), equivalent to 0.08% ± 0.05% 4 and 0.02% ± 0.03% of the infused amount of 13C-T, respectively. The cumulative excretion of 13C-3a-Diol was 67.7 ± 19.9 μg/24 hours (men) and 10.0 ± 6.0 μg/24 hours (women), equivalent to 0.3 ± 0.1% and 0.2 ± 0.1% of the infused dose of 13C-labeled testosterone, respectively. © 1992.

引用

页码：177 / 180

页数：4

共 16 条

[1]

Morimoto, Edmiston, Hawks, Horton, Studies on the origin of androstanediol and androstanediol glucuronide in young and elderly men, J Clin Endocrinol Metab, 52, pp. 772-778, (1981)

[2]

Baulieu, Mauvais-Jarvis, Studies of testosterone metabolism. 1. Conversion of testosterone-17α-<sup>3</sup>H to 5α- and 5β- androstane-3α, 17β-diol-17α-<sup>3</sup>H: a new “17β-hydroxyl pathway.”, J Biol Chem, 239, pp. 1569-1577, (1964)

[3]

Baba, Shinohara, Kasuya, Differentiation between endogenous and exogenous testosterone in human plasma and urine after oral administration of deuterium-labelled testosterone by mass fragmentography, J Clin Endocrinol Metab, 50, pp. 889-894, (1980)

[4]

Vierhapper, Nowotny, Waldhausl, Estimation by gas chromatography-mass spectrometry with selected ion monitoring of urinary excretion rates of 3a-androstanediol during/after i.v. administration of 13-C labelled testosterone in man, J. Steroid Biochem, 29, pp. 105-109, (1988)

[5]

Nowotny, Vierhapper, Waldhausl, Estimation of metabolic clearance rate of testosterone and its conversion to 5a-androstanediol in women by means of stable-labeled 13C-testosterone, 71 st Annual Meeting of the Endocrine Society, (1989)

[6]

Jacolot, Berthou, Dreano, Bercovici, Floch, In vivo metabolism of 14C-labelled 5a-androstane-3β,17β-diol, J Steroid Biochem, 14, pp. 663-669, (1981)

[7]

Mauvais-Jarvis, Bercovici, Gauthier, Studies on testicular metabolism in subjects with testicular feminization syndrome, J Clin Invest, 49, pp. 31-40, (1970)

[8]

Peterson, Imperato-McGinley, Gautier, Sturla, Male pseudohermaphroditism due to steroid 5a-reductase deficiency, Am J Med, 62, pp. 170-191, (1977)

[9]

Mauvais-Jarvis, Charransol, Bobas-Masson, Simultaneous determination of urinary androstanediol and testosterone as an evaluation of human androgenicity, J Clin Endocrinol Metab, 36, pp. 452-459, (1973)

[10]

Deslypere, Sayed, Punjabi, Verdonck, Vermeulen, Plasma 5α-androstane-3α,17β-diol and urinary 5α-androstane-3, 17β-diol glucuronide, parameters of peripheral androgen action: a comparative study, J clin Endocrinol Metab, 54, pp. 386-391, (1982)

← 1 2 →